Birinyi Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822K | Hold |
1,055
| – | – | 0.24% | 38 |
|
|
2025
Q1 | $871K | Hold |
1,055
| – | – | 0.28% | 36 |
|
|
2024
Q4 | $814K | Sell |
1,055
-3,953
| -79% | -$3.05M | 0.22% | 38 |
|
|
2024
Q3 | $4.44M | Buy |
5,008
+228
| +5% | +$202K | 1.27% | 17 |
|
|
2024
Q2 | $4.33M | Buy |
4,780
+2,105
| +79% | +$1.91M | 1.3% | 18 |
|
|
2024
Q1 | $2.08M | Buy |
2,675
+1,046
| +64% | +$814K | 0.68% | 24 |
|
|
2023
Q4 | $950K | Buy |
1,629
+879
| +117% | +$513K | 0.34% | 36 |
|
|
2023
Q3 | $403K | Hold |
750
| – | – | 0.16% | 45 |
|
|
2023
Q2 | $352K | Sell |
750
-950
| -56% | -$446K | 0.13% | 51 |
|
|
2023
Q1 | $584K | Buy |
+1,700
| New | +$584K | 0.24% | 46 |
|
|
2022
Q4 | – | Sell |
-1,550
| Closed | -$501K | – | 58 |
|
|
2022
Q3 | $501K | Buy |
+1,550
| New | +$501K | 0.23% | 43 |
|
|
2021
Q4 | – | Sell |
-900
| Closed | -$208K | – | 66 |
|
|
2021
Q3 | $208K | Buy |
+900
| New | +$208K | 0.07% | 66 |
|
|
2019
Q4 | – | Sell |
-4,000
| Closed | -$447K | – | 78 |
|
|
2019
Q3 | $447K | Sell |
4,000
-100
| -2% | -$11.2K | 0.19% | 55 |
|
|
2019
Q2 | $454K | Buy |
+4,100
| New | +$454K | 0.19% | 55 |
|